Literature DB >> 28865344

Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir.

Jonna B Westover1, Johanna D Rigas2, Arnaud J Van Wettere2, Rong Li1, Brady T Hickerson1, Kie-Hoon Jung1, Jinxin Miao3, Erin S Reynolds4, Bettina L Conrad5, Skot Nielson1, Yousuke Furuta6, Saravanan Thangamani4, Zhongde Wang1, Brian B Gowen7.   

Abstract

Heartland virus (HRTV) is an emerging tick-borne virus (Bunyaviridae, Phlebovirus) that has caused sporadic cases of human disease in several central and mid-eastern states of America. Animal models of HRTV disease are needed to gain insights into viral pathogenesis and advancing antiviral drug development. Presence of clinical disease following HRTV challenge in hamsters deficient in STAT2 function underscores the important role played by type I interferon-induced antiviral responses. However, the recovery of most of the infected animals suggests that other mechanisms to control infection and limit disease offer substantial protection. The most prominent disease sign with HRTV infection in STAT2 knockout hamsters was dramatic weight loss with clinical laboratory and histopathology demonstrating acute inflammation in the spleen, lymph node, liver and lung. Finally, we show that HRTV disease in hamsters can be prevented by the use of favipiravir, a promising broad-spectrum antiviral in clinical development for the treatment of influenza.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal model; Favipiravir; Heartland virus; Phlebovirus; Severe fever with thrombocytopenia syndrome virus; Type I interferon

Mesh:

Substances:

Year:  2017        PMID: 28865344      PMCID: PMC5623653          DOI: 10.1016/j.virol.2017.08.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Serological investigation of heartland virus (Bunyaviridae: Phlebovirus) exposure in wild and domestic animals adjacent to human case sites in Missouri 2012-2013.

Authors:  Angela M Bosco-Lauth; Nicholas A Panella; J Jeffrey Root; Tom Gidlewski; R Ryan Lash; Jessica R Harmon; Kristen L Burkhalter; Marvin S Godsey; Harry M Savage; William L Nicholson; Nicholas Komar; Aaron C Brault
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

2.  Novel Clinical and Pathologic Findings in a Heartland Virus-Associated Death.

Authors:  Mary-Margaret A Fill; Margaret L Compton; Edward C McDonald; Abelardo C Moncayo; John R Dunn; William Schaffner; Julu Bhatnagar; Sherif R Zaki; Timothy F Jones; Wun-Ju Shieh
Journal:  Clin Infect Dis       Date:  2017-02-15       Impact factor: 9.079

3.  Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir.

Authors:  Brian B Gowen; Jonna B Westover; Jinxin Miao; Arnaud J Van Wettere; Johanna D Rigas; Brady T Hickerson; Kie-Hoon Jung; Rong Li; Bettina L Conrad; Skot Nielson; Yousuke Furuta; Zhongde Wang
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.

Authors:  Dionna Scharton; Kevin W Bailey; Zachary Vest; Jonna B Westover; Yohichi Kumaki; Arnaud Van Wettere; Yousuke Furuta; Brian B Gowen
Journal:  Antiviral Res       Date:  2014-01-31       Impact factor: 5.970

Review 5.  Favipiravir (T-705), a novel viral RNA polymerase inhibitor.

Authors:  Yousuke Furuta; Brian B Gowen; Kazumi Takahashi; Kimiyasu Shiraki; Donald F Smee; Dale L Barnard
Journal:  Antiviral Res       Date:  2013-09-29       Impact factor: 5.970

6.  Development and Characterization of Monoclonal Antibodies Directed Against the Nucleoprotein of Heartland Virus.

Authors:  Amanda E Calvert; Aaron C Brault
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

Review 7.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

8.  Vertebrate Host Susceptibility to Heartland Virus.

Authors:  Angela M Bosco-Lauth; Amanda E Calvert; J Jeffrey Root; Tom Gidlewski; Brian H Bird; Richard A Bowen; Atis Muehlenbachs; Sherif R Zaki; Aaron C Brault
Journal:  Emerg Infect Dis       Date:  2016-12       Impact factor: 6.883

9.  Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever.

Authors:  Amy L Caroline; Diana S Powell; Laura M Bethel; Tim D Oury; Douglas S Reed; Amy L Hartman
Journal:  PLoS Negl Trop Dis       Date:  2014-04-10

10.  Immune Cell Targets of Infection at the Tick-Skin Interface during Powassan Virus Transmission.

Authors:  Meghan E Hermance; Rodrigo I Santos; Brent C Kelly; Gustavo Valbuena; Saravanan Thangamani
Journal:  PLoS One       Date:  2016-05-20       Impact factor: 3.240

View more
  13 in total

1.  Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.

Authors:  Colm Atkins; Jinxin Miao; Birte Kalveram; Terry Juelich; Jennifer K Smith; David Perez; Lihong Zhang; Jonna L B Westover; Arnaud J Van Wettere; Brian B Gowen; Zhongde Wang; Alexander N Freiberg
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

2.  Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1.

Authors:  Kuan Feng; Fei Deng; Zhihong Hu; Hualin Wang; Yun-Jia Ning
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

3.  The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses.

Authors:  Crystal A Mendoza; Satoko Yamaoka; Yoshimi Tsuda; Keita Matsuno; Carla M Weisend; Hideki Ebihara
Journal:  Antiviral Res       Date:  2020-12-06       Impact factor: 5.970

Review 4.  Tick-Borne Viruses.

Authors:  Junming Shi; Zhihong Hu; Fei Deng; Shu Shen
Journal:  Virol Sin       Date:  2018-03-13       Impact factor: 4.327

5.  A novel tick-borne phlebovirus, closely related to severe fever with thrombocytopenia syndrome virus and Heartland virus, is a potential pathogen.

Authors:  Shu Shen; Xiaomei Duan; Bo Wang; Liying Zhu; Yanfang Zhang; Jingyuan Zhang; Jun Wang; Tao Luo; Chun Kou; Dan Liu; Chuanwei Lv; Lei Zhang; Chenchen Chang; Zhengyuan Su; Shuang Tang; Jie Qiao; Abulimiti Moming; Cheng Wang; Abulikemu Abudurexiti; Hualin Wang; Zhihong Hu; Yujiang Zhang; Surong Sun; Fei Deng
Journal:  Emerg Microbes Infect       Date:  2018-05-25       Impact factor: 7.163

Review 6.  Syrian Hamster as an Animal Model for the Study on Infectious Diseases.

Authors:  Jinxin Miao; Louisa S Chard; Zhimin Wang; Yaohe Wang
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

7.  Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis.

Authors:  Charlene Ranadheera; Emelissa J Valcourt; Bryce M Warner; Guillaume Poliquin; Kyle Rosenke; Kathy Frost; Kevin Tierney; Greg Saturday; Jinxin Miao; Jonna B Westover; Brian B Gowen; Stephanie Booth; Heinz Feldmann; Zhongde Wang; David Safronetz
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.996

Review 8.  Heartland Virus Epidemiology, Vector Association, and Disease Potential.

Authors:  Aaron C Brault; Harry M Savage; Nisha K Duggal; Rebecca J Eisen; J Erin Staples
Journal:  Viruses       Date:  2018-09-14       Impact factor: 5.048

9.  Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration.

Authors:  Hideki Tani; Takashi Komeno; Aiko Fukuma; Shuetsu Fukushi; Satoshi Taniguchi; Masayuki Shimojima; Akihiko Uda; Shigeru Morikawa; Nozomi Nakajima; Yousuke Furuta; Masayuki Saijo
Journal:  PLoS One       Date:  2018-10-26       Impact factor: 3.240

10.  First report of Lihan Tick virus (Phlebovirus, Phenuiviridae) in ticks, Colombia.

Authors:  Yesica López; Jorge Miranda; Salim Mattar; Marco Gonzalez; Joel Rovnak
Journal:  Virol J       Date:  2020-05-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.